Paul Slobbe
Impact in
- Organic Chemistry top 5%
- Multicomponent Synthesis of Heterocycles
- Synthesis and biological activity
- Chemical Synthesis and Reactions
- Synthesis and Biological Evaluation
- Click Chemistry and Applications
-
- Synthesis of Organic Compounds
Papers in
-
- Lung Cancer Treatments and Mutations 3
- Oncology 3
- HER2/EGFR in Cancer Research 3
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Romano V. A. Orrù (2 shared papers)Eelco Ruijter (2 shared papers)Albert D. Windhorst (7 shared papers)Alex J. Poot (7 shared papers)Guus A.M.S. van Dongen (5 shared papers)Egbert F. Smit (2 shared papers)Heiko G. Niessen (2 shared papers)Marijke Stigter‐van Walsum (2 shared papers)
- Journals
- Nuclear Medicine and Biology (2 papers)The Journal of Organic Chemistry (1 paper)Drug Discovery Today (1 paper)MedChemComm (1 paper)Oncotarget (1 paper)
- Partner nations
- NetherlandsGermanyAustria
In The Last Decade
Paul Slobbe
10 papers receiving 612 citations
Paul Slobbe's Hit Papers
Peers
Comparison fields: 5 of 51
- Organic Chemistry 429
- Pharmacology 63
- Toxicology 13
- Radiology, Nuclear Medicine and Imaging 72
- Oncology 80
Countries citing papers authored by Paul Slobbe
This map shows the geographic impact of Paul Slobbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Slobbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Slobbe more than expected).
Fields of papers citing papers by Paul Slobbe
This network shows the impact of papers produced by Paul Slobbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Slobbe. The network helps show where Paul Slobbe may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Slobbe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Recent applications of multicomponent reactions in medicinal chemistry Hit paper breakdown → | 2012 | 435 |
| 2 | 2012 | 54 | |
| 3 | 2015 | 40 | |
| 4 | 2014 | 38 | |
| 5 | 2012 | 13 | |
| 6 | 2016 | 12 | |
| 7 | 2012 | 11 | |
| 8 | 2017 | 6 | |
| 9 | 2014 | 5 | |
| 10 | [11C]nintedanib as TKI-PET tracer for angiogenesis imaging in vivo. | 2016 | 1 |
About Paul Slobbe
Paul Slobbe is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Organic Chemistry and Molecular Biology, having authored 10 papers that have together received 615 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers), HER2/EGFR in Cancer Research (3 papers), Colorectal Cancer Treatments and Studies (1 paper), Tuberculosis Research and Epidemiology (1 paper), Synthesis and Characterization of Heterocyclic Compounds (1 paper), Melanoma and MAPK Pathways (1 paper) and Asymmetric Synthesis and Catalysis (1 paper). The work is most often cited by research in Organic Chemistry (429 citations), Pharmacology (63 citations), Toxicology (13 citations), Radiology, Nuclear Medicine and Imaging (72 citations) and Oncology (80 citations). Paul Slobbe has collaborated with scholars based in Netherlands, Germany and Austria. Frequent co-authors include Romano V. A. Orrù, Eelco Ruijter, Albert D. Windhorst, Alex J. Poot, Guus A.M.S. van Dongen, Egbert F. Smit, Heiko G. Niessen, Marijke Stigter‐van Walsum, Flavio Solca and G. Stehle. Their work appears in journals such as Nuclear Medicine and Biology, The Journal of Organic Chemistry, Drug Discovery Today, MedChemComm and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.